AXL is highly expressed in a variety of tumor types, including ovarian, breast, lung and renal cancers, and its expression correlates with poor patient survival through the regulation of invasion, metastasis, drug resistance and immune suppression [11,13,14,15,16,17,18,19]. Here, AXL is linked to neoplasm.